Package 0078-0469-15

Brand: exjade

Generic: deferasirox
NDC Package

Package Facts

Identity

Package NDC 0078-0469-15
Digits Only 0078046915
Product NDC 0078-0469
Product ID 0078-0469_17c39217-5502-420d-8d2e-799626756189
Description

30 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0469-15)

Marketing

Marketing Status
Marketed Since 2005-11-30
Brand exjade
Generic deferasirox
Sample Package No

Linked Drug Pages (1)

Exjade ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "17c39217-5502-420d-8d2e-799626756189", "openfda": {"nui": ["N0000000144", "N0000175522", "N0000185506", "N0000187062", "N0000182138"], "unii": ["V8G4MOF2V9"], "rxcui": ["597768", "597770", "597772", "616159", "616161", "616163"], "spl_set_id": ["3495a70c-870c-4968-940e-8baea152cf85"], "pharm_class_epc": ["Iron Chelator [EPC]"], "pharm_class_moa": ["Iron Chelating Activity [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0469-15)", "package_ndc": "0078-0469-15", "marketing_start_date": "20051130"}], "brand_name": "Exjade", "product_id": "0078-0469_17c39217-5502-420d-8d2e-799626756189", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "0078-0469", "generic_name": "deferasirox", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Exjade", "active_ingredients": [{"name": "DEFERASIROX", "strength": "250 mg/1"}], "application_number": "NDA021882", "marketing_category": "NDA", "marketing_start_date": "20051130", "listing_expiration_date": "20271231"}